Type 1 Diabetes
A Study of LY900014 in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps
The purpose of this study is to investigate how the human body processes LY900014 and its effect on blood sugar levels when it is delivered via an insulin pump to participants with type 1 diabetes mellitus. Side effects and tolerability will be documented.
The results of this study are not yet available.
Your participation could last up to 11 weeks and include 12 visits to the study center.
Here you can find out a bit more about the requirements for volunteers who took part in this study
Participants must have Type 1 Diabetes Mellitus (T1DM) and are receiving insulin therapy via an approved insulin pump
Participants must have a body mass index (BMI) of 18.5 to 33
Participants must have had no episodes of severe hypoglycemia in the past 6 months
Participants must not have had blood loss of more than 500 milliliters (mL) within the last month
Participants must not have previously participated or withdrawn from this study